Cardinal Health margins, shrs could rise-Barron's
NEW YORK, Nov 8 (Reuters) - Shares of Cardinal Health (CAH.N: Quote, Profile, Research), the No. 2 U.S. drug distributor, should continue climbing, Barron's magazine said on Sunday.
Cardinal is up 19 percent since it spun off its medical technology unit, CareFusion (CFN.N: Quote, Profile, Research), but its stock has greater potential to rise in price compared with that of rivals McKesson (MCK.N: Quote, Profile, Research) and AmerisourceBergen (ABC.N: Quote, Profile, Research).
The stock could rally into the low $40s per share, the paper said, as Cardinal management focuses its attention on boosting profit margins in pharmaceuticals distribution. Sales could also rise as the economy improves and more generics drugs are introduced.
(Reporting by Joseph A. Giannone; Editing Bernard Orr)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India. Full Coverage
GLOBAL RECOVERY
Global economy in holding pattern - IMF
The global economy is in a holding pattern and vulnerable to more upheaval, the head of the IMF said, adding a lasting recovery will depend on policymakers taking the proper steps in the coming months. Full Article
India
US
UK
